Skip to main content

Articles

Page 1 of 60

  1. Serum uric acid (SUA) is an important pathogenetic and prognostic factor for heart failure (HF). Gender differences are apparent in HF. Furthermore, gender differences also exist in the association between SUA...

    Authors: Kang Fu, Congyi Cheng, Cong Su, Junlin Teng, Lei Qiao, Jie Xiao, Xiaoping Ji, Huixia Lu and Wenqiang Chen
    Citation: Cardiovascular Diabetology 2024 23:131
    Content type: Research Published on:

  2. Fasting glucose (FG) demonstrates dynamic fluctuations over time and is associated with cardiovascular outcomes, yet current research is limited by small sample sizes and relies solely on baseline glycemic lev...

    Authors: Mianli Xiao, Markku A. Malmi Jr., Douglas D. Schocken, Janice C. Zgibor and Amy C. Alman
    Citation: Cardiovascular Diabetology 2024 23:130
    Content type: Research Published on:

  3. The long-term high-fat diet (HFD) can cause myocardial lipotoxicity, which is characterized pathologically by myocardial hypertrophy, fibrosis, and remodeling and clinically by cardiac dysfunction and heart fa...

    Authors: Xinzhu Ni, Lian Duan, Yandong Bao, Jinyang Li, Xiaowen Zhang, Dalin Jia and Nan Wu
    Citation: Cardiovascular Diabetology 2024 23:129
    Content type: Research Published on:

  4. Compelling evidence suggests that calcium/phosphorus homeostasis-related parameters may be linked to diabetes mellitus and cardiovascular events. However, few studies have investigated the association of fibro...

    Authors: Jiao Bi, Mei Zheng, Ke Li, Siwei Sun, Zihang Zhang, Nana Yan and Xueping Li
    Citation: Cardiovascular Diabetology 2024 23:128
    Content type: Research Published on:

  5. Type 2 diabetes (T2D) and peripheral artery disease (PAD) are recognized as independent risk factors contributing to excess mortality. Contemporary observational studies exploring the associations of risk fact...

    Authors: Tarik Avdic, Hanne K. Carlsen, Aidin Rawshani, Soffia Gudbjörnsdottir, Zacharias Mandalenakis and Björn Eliasson
    Citation: Cardiovascular Diabetology 2024 23:127
    Content type: Research Published on:

  6. The accumulation of visceral and ectopic fat comprise a major cause of cardiometabolic diseases. However, novel drug targets for reducing unnecessary visceral and ectopic fat are still limited. Our study aims ...

    Authors: Min Cao and Bin Cui
    Citation: Cardiovascular Diabetology 2024 23:126
    Content type: Research Published on:

  7. Hypertension and chronic kidney disease (CKD) pose significant public health challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized as a precursor to diabetes and is often acc...

    Authors: Gaetano Santulli, Valeria Visco, Michele Ciccarelli, Mario Nicola Vittorio Ferrante, Piero De Masi, Antonella Pansini, Nicola Virtuoso, Armando Pirone, Germano Guerra, Veronica Verri, Gaetano Macina, Alessandro Taurino, Klara Komici and Pasquale Mone
    Citation: Cardiovascular Diabetology 2024 23:125
    Content type: Research Published on:

  8. Individuals with type 2 diabetes (T2D) are at increased risk of developing cardiovascular disease (CVD) which necessitates monitoring of risk factors and appropriate pharmacotherapy. This study aimed to identi...

    Authors: Björn Agvall, Junmei Miao Jonasson, Alexander Galozy and Anders Halling
    Citation: Cardiovascular Diabetology 2024 23:124
    Content type: Research Published on:

  9. Diabetes is a predominant driver of coronary artery disease worldwide. This study aims to unravel the distinct characteristics of oral and gut microbiota in diabetic coronary heart disease (DCHD). Simultaneous...

    Authors: Yiwen Li, Yanfei Liu, Jing Cui, Mengmeng Zhu, Wenting Wang, Keji Chen, Luqi Huang and Yue Liu
    Citation: Cardiovascular Diabetology 2024 23:123
    Content type: Research Published on:

  10. Histone modifications play a critical role in chromatin remodelling and regulate gene expression in health and disease. Histone methyltransferases EZH1, EZH2, and demethylases UTX, JMJD3, and UTY catalyse trim...

    Authors: Julia Sánchez-Ceinos, Shafaat Hussain, Abdul Waheed Khan, Liang Zhang, Wael Almahmeed, John Pernow and Francesco Cosentino
    Citation: Cardiovascular Diabetology 2024 23:122
    Content type: Research Published on:

  11. This study investigates the relationship between triglyceride-glucose (TyG) index trajectories and the results of ablation in patients with stage 3D atrial fibrillation (AF).

    Authors: Sixiang Jia, Yanping Yin, Xuanting Mou, Jing Zheng, Zhe Li, Tianli Hu, Jianqiang Zhao, Jiangbo Lin, Jiaqi Song, Fanli Cheng, Yiran Wang, Kaini Li, Wenting Lin, Chao Feng, Weili Ge and Shudong Xia
    Citation: Cardiovascular Diabetology 2024 23:121
    Content type: Research Published on:

  12. Obesity is often associated with multiple comorbidities. However, whether obese subjects with hyperlipidemia in the absence of other complications have worse cardiac indices than metabolically healthy obese su...

    Authors: Jing Liu, Jing Li, Chunchao Xia, Wenzhang He, Xue Li, Sumin Shen, Xiaoyue Zhou, Nanwei Tong and Liqing Peng
    Citation: Cardiovascular Diabetology 2024 23:120
    Content type: Research Published on:

  13. Atherogenic index of plasma (AIP) represents a novel marker in the current era of cardiovascular diseases. In this meta-analysis, we aimed to evaluate the association of AIP with cardiovascular prognosis in pa...

    Authors: Mehrdad Rabiee Rad, Ghazal Ghasempour Dabaghi, Bahar Darouei and Reza Amani-Beni
    Citation: Cardiovascular Diabetology 2024 23:119
    Content type: Review Published on:

  14. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are increasingly recognized for their role in reducing the risk and improving the prognosis of heart failure (HF). However, the precise mechanisms involved re...

    Authors: Wenqin Guo, Lingyue Zhao, Weichao Huang, Jing Chen, Tingting Zhong, Shaodi Yan, Wei Hu, Fanfang Zeng, Changnong Peng and Hongbing Yan
    Citation: Cardiovascular Diabetology 2024 23:118
    Content type: Research Published on:

  15. Identifying reliable prognostic markers is crucial for the effective management of hypertension. The neutrophil-to-lymphocyte ratio (NLR) has emerged as a potential inflammatory marker linked to cardiovascular...

    Authors: Xuexue Zhang, Rui Wei, Xujie Wang, Wantong Zhang, Mengxuan Li, Tian Ni, Weiliang Weng and Qiuyan Li
    Citation: Cardiovascular Diabetology 2024 23:117
    Content type: Research Published on:

  16. Diabetic cardiomyopathy (DCM) is a serious complication in patients with type 1 diabetes mellitus (T1DM), which still lacks adequate therapy. Irisin, a cleavage peptide off fibronectin type III domain-containi...

    Authors: Yuan-juan Tang, Zhen Zhang, Tong Yan, Ken Chen, Guo-fan Xu, Shi-qiang Xiong, Dai-qian Wu, Jie Chen, Pedro A. Jose, Chun-yu Zeng and Jin-juan Fu
    Citation: Cardiovascular Diabetology 2024 23:116
    Content type: Research Published on:

  17. Diabetes mellitus (DM) duration affects incident atrial fibrillation (AF) risk; the effect of physical activity on mitigating AF risk related to varying DM duration remains unknown. We assessed the effect of p...

    Authors: JungMin Choi, So‑Ryoung Lee, Eue-Keun Choi, Kyung-Yeon Lee, Hyo-Jeong Ahn, Soonil Kwon, Kyung‑Do Han, Seil Oh and Gregory Y. H. Lip
    Citation: Cardiovascular Diabetology 2024 23:115
    Content type: Research Published on:

  18. Since the complication of diabetes mellitus (DM) is a risk for adverse cardiovascular outcomes in patients with coronary artery disease (CAD), appropriate risk estimation is needed in diabetic patients followi...

    Authors: Yuichi Chikata, Hiroshi Iwata, Katsutoshi Miyosawa, Ryo Naito, Takuma Koike, Soshi Moriya, Hidetoshi Yasuda, Takehiro Funamizu, Shinichiro Doi, Hirohisa Endo, Hideki Wada, Manabu Ogita, Tomotaka Dohi, Takatoshi Kasai, Kikuo Isoda, Shinya Okazaki…
    Citation: Cardiovascular Diabetology 2024 23:114
    Content type: Research Published on:

  19. The hemoglobin glycation index (HGI) is the difference between the observed and predicted values of glycosylated hemoglobin (HbA1c), which is closely associated with a variety of poor prognoses. However, there...

    Authors: Xing Wei, Xinghua Chen, Zhipeng Zhang, Jing Wei, Ben Hu, Nv Long, Jun Feng and Chunmiao Luo
    Citation: Cardiovascular Diabetology 2024 23:113
    Content type: Research Published on:

  20. Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are effective antidiabetic drugs with potential cardiovascular benefits. Despite their well-established role in reducing the risk of major adverse cardiovas...

    Authors: Fatemeh Taktaz, Lucia Scisciola, Rosaria Anna Fontanella, Ada Pesapane, Puja Ghosh, Martina Franzese, Giovanni Tortorella, Armando Puocci, Eduardo Sommella, Giuseppe Signoriello, Fabiola Olivieri, Michelangela Barbieri and Giuseppe Paolisso
    Citation: Cardiovascular Diabetology 2024 23:112
    Content type: Research Published on:

  22. The reduction of myocardial infarction (MI) and narrowing the gap between the populations with and without diabetes are important goals of diabetes care. We analyzed time trends for sex-specific incidence rate...

    Authors: Heiner Claessen, Maria Narres, Margit Heier, Tatjana Kvitkina, Birgit Linkohr, Georg Wolff, Michael Roden, Andrea Icks and Annette Peters
    Citation: Cardiovascular Diabetology 2024 23:110
    Content type: Research Published on:

  23. In this study, we evaluated the lipidome alterations caused by type 1 diabetes (T1D) and type 2 diabetes (T2D), by determining lipids significantly associated with diabetes overall and in both sexes, and lipid...

    Authors: Maria Barranco-Altirriba, Núria Alonso, Ralf J. M. Weber, Gavin R. Lloyd, Marta Hernandez, Oscar Yanes, Jordi Capellades, Andris Jankevics, Catherine Winder, Mireia Falguera, Josep Franch-Nadal, Warwick B Dunn, Alexandre Perera-Lluna, Esmeralda Castelblanco and Didac Mauricio
    Citation: Cardiovascular Diabetology 2024 23:109
    Content type: Research Published on:

  24. Coronary inflammation plays crucial role in type 2 diabetes mellitus (T2DM) induced cardiovascular complications. Both glucose-lowering drug interventions (GLDIS) and glycemic control (GC) status potentially c...

    Authors: Yuankang Liu, Lisong Dai, Yue Dong, Cong Ma, Panpan Cheng, Cuiping Jiang, Hongli Liao, Ying Li, Xiang Wang and Xiangyang Xu
    Citation: Cardiovascular Diabetology 2024 23:108
    Content type: Research Published on:

  25. Diabetes-induced trained immunity contributes to the development of atherosclerosis and its complications. This study aimed to investigate in humans whether epigenetic signals involved in immune cell activatio...

    Authors: Maria Cristina Vinci, Sarah Costantino, Giulia Damiano, Erica Rurali, Raffaella Rinaldi, Vera Vigorelli, Annalisa Sforza, Ermes Carulli, Sergio Pirola, Giorgio Mastroiacovo, Angela Raucci, Assam El-Osta, Francesco Paneni and Giulio Pompilio
    Citation: Cardiovascular Diabetology 2024 23:107
    Content type: Research Published on:

  26. This study aimed to investigate the association of sodium-glucose cotransporter 2 inhibitors (SGLT2i) use with cardiovascular (CV) clinical outcomes in type 2 diabetes (T2D) patients with acute coronary syndro...

    Authors: Tao Liu, Zeyuan Fan, Bing Xiao, Chang He and Shicong Wang
    Citation: Cardiovascular Diabetology 2024 23:106
    Content type: Research Published on:

  27. Imeglimin is a new anti-diabetic drug which promotes insulin secretion from pancreatic β-cells and reduces insulin resistance in insulin target tissues. However, there have been no reports examining the possib...

    Authors: Junpei Sanada, Tomohiko Kimura, Masashi Shimoda, Yuichiro Iwamoto, Hideyuki Iwamoto, Kazunori Dan, Yoshiro Fushimi, Yukino Katakura, Yuka Nogami, Yoshiko Shirakiya, Yuki Yamasaki, Tomoko Ikeda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku and Hideaki Kaneto
    Citation: Cardiovascular Diabetology 2024 23:105
    Content type: Research Published on:

  28. The 9th Cardiovascular Outcome Trial (CVOT) Summit: Congress on Cardiovascular, Kidney, and Metabolic Outcomes was held virtually on November 30-December 1, 2023. This reference congress served as a platform f...

    Authors: Oliver Schnell, Katharine Barnard-Kelly, Tadej Battelino, Antonio Ceriello, Helena Elding Larsson, Beatriz Fernández-Fernández, Thomas Forst, Juan-Pablo Frias, James R. Gavin III, Francesco Giorgino, Per-Henrik Groop, Hiddo J. L. Heerspink, Stephan Herzig, Michael Hummel, George Huntley, Mahmoud Ibrahim…
    Citation: Cardiovascular Diabetology 2024 23:104
    Content type: Comment Published on:

  29. Authors: Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik and Elisabetta Patorno
    Citation: Cardiovascular Diabetology 2024 23:103
    Content type: Correction Published on:

    The original article was published in Cardiovascular Diabetology 2024 23:57

  30. There is a paucity of contemporary data on the prevalence and prognostic significance of cardiac autonomic neuropathy (CAN) from community-based cohorts with type 2 diabetes assessed using gold standard method...

    Authors: Timothy M. E. Davis, Eva Tan and Wendy A. Davis
    Citation: Cardiovascular Diabetology 2024 23:102
    Content type: Research Published on:

  31. The cumulative effect of postpartum weight retention from each pregnancy in a woman’s life may contribute to her risk of ultimately developing type 2 diabetes and cardiovascular disease. However, there is limi...

    Authors: Caroline K. Kramer, Chang Ye, Anthony J Hanley, Philip W Connelly, Mathew Sermer, Bernard Zinman and Ravi Retnakaran
    Citation: Cardiovascular Diabetology 2024 23:101
    Content type: Research Published on:

  32. Hemorrhagic stroke (HS), including non-traumatic intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH), constitutes a substantial proportion of cerebrovascular incidents, accounting for around 30% o...

    Authors: Yongwei Huang, Zongping Li and Xiaoshuang Yin
    Citation: Cardiovascular Diabetology 2024 23:100
    Content type: Research Published on:

  33. Randomized controlled trials and real-world studies suggest that combination therapy with sodium–glucose transport protein 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) is ass...

    Authors: Aftab Ahmad and Hani Sabbour
    Citation: Cardiovascular Diabetology 2024 23:99
    Content type: Research Published on:

  34. Telomere Length (TL), a marker of cellular aging, holds promise as a biomarker to elucidate the molecular mechanism of diabetes. This study aimed to investigate whether shorter telomeres are associated with a ...

    Authors: Ana Ojeda-Rodriguez, Oriol A. Rangel-Zuñiga, Antonio P. Arenas-de Larriva, Francisco M. Gutierrez-Mariscal, Jose D. Torres-Peña, Juan L. Romero-Cabrera, Alicia Podadera-Herreros, Helena García-Fernandez, Esther Porras-Pérez, Raul M. Luque, Stefanos N. Kales, Pablo Perez-Martinez, Javier Delgado-Lista, Elena M. Yubero-Serrano and Jose Lopez-Miranda
    Citation: Cardiovascular Diabetology 2024 23:98
    Content type: Research Published on:

  35. Tissue-specific insulin resistance (IR) predominantly in muscle (muscle IR) or liver (liver IR) has previously been linked to distinct fasting metabolite profiles, but postprandial metabolite profiles have not...

    Authors: Anouk Gijbels, Balázs Erdős, Inez Trouwborst, Kelly M. Jardon, Michiel E. Adriaens, Gijs H. Goossens, Ellen E. Blaak, Edith J. M. Feskens and Lydia A. Afman
    Citation: Cardiovascular Diabetology 2024 23:97
    Content type: Research Published on:

  36. Diabetic cardiomyopathy (DCM) is a major contributor to mortality in diabetic patients, characterized by a multifaceted pathogenesis and limited therapeutic options. While lactate, a byproduct of glycolysis, i...

    Authors: Xiu Mei Ma, Kang Geng, Peng Wang, Zongzhe Jiang, Betty Yuen-Kwan Law and Yong Xu
    Citation: Cardiovascular Diabetology 2024 23:96
    Content type: Research Published on:

  37. The association of the triglyceride-glucose (TyG) index with intracranial atherosclerotic stenosis (ICAS) and extracranial atherosclerotic stenosis (ECAS) is unclear. This study aimed to investigate the relati...

    Authors: Yu Xie, Kuan Cen, Bitang Dan, Li Zou, Lei Zhang, Renwei Zhang, Huagang Li, Qi Cai, Nadire Aiziretiaili, Zhenxing Liu and Yumin Liu
    Citation: Cardiovascular Diabetology 2024 23:95
    Content type: Research Published on:

  38. Originally designed as anti-hyperglycemic drugs, Glucagon-Like Peptide-1 receptor agonists (GLP-1Ra) and Sodium-glucose cotransporter-2 inhibitors (SGLT2i) have demonstrated protective cardiovascular effects, ...

    Authors: Angelica Cersosimo, Nadia Salerno, Jolanda Sabatino, Alessandra Scatteia, Giandomenico Bisaccia, Salvatore De Rosa, Santo Dellegrottaglie, Chiara Bucciarelli-Ducci, Daniele Torella and Isabella Leo
    Citation: Cardiovascular Diabetology 2024 23:94
    Content type: Review Published on:

  39. Stress hyperglycemia ratio (SHR) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) are independently associated with increased mortality risk in diabetic patients with coronary artery disease (CAD). Ho...

    Authors: Le Wang, Chen Wang, Jia-chun Lang, Rong-di Xu, Hong‑liang Cong, Jing‑xia Zhang, Yue‑cheng Hu, Ting-ting Li, Chun-wei Liu, Hua Yang and Wen‑yu Li
    Citation: Cardiovascular Diabetology 2024 23:93
    Content type: Research Published on:

  40. Research on identifiable risks for metabolic syndrome (MetS) is ongoing, and growing evidence suggests that bilirubin is a potent antioxidant and cytoprotective agent against MetS. Ho...

    Authors: Ae Hee Kim, Da-Hye Son, Mid-Eum Moon, Soyoung Jeon, Hye Sun Lee and Yong-Jae Lee
    Citation: Cardiovascular Diabetology 2024 23:92
    Content type: Research Published on:

  41. Recent guidelines propose N-terminal pro-B-type natriuretic peptide (NT-proBNP) for recognition of asymptomatic left ventricular (LV) dysfunction (Stage B Heart Failure, SBHF) in type 2 diabetes mellitus (T2DM...

    Authors: Cheng Hwee Soh, Alex G. C. de Sá, Elizabeth Potter, Amera Halabi, David B. Ascher and Thomas H. Marwick
    Citation: Cardiovascular Diabetology 2024 23:91
    Content type: Research Published on:

  42. Atrial fibrillation (AF) has been linked to an increased risk of cardiovascular death, overall mortality and heart failure in patients with type 2 diabetes mellitus (T2DM). The present study investigated the a...

    Authors: Xue-Ming Li, Wei-Feng Yan, Ke Shi, Rui Shi, Li Jiang, Yue Gao, Chen-Yan Min, Xiao-Jing Liu, Ying-Kun Guo and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2024 23:90
    Content type: Research Published on:

  43. Platelets play an important role in the development of cardiovascular disease (CVD). Mean platelet volume (MPV) is considered as biological marker of platelets activity and function. The aim of the present stu...

    Authors: Velia Cassano, Giuseppe Armentaro, Domenico Iembo, Sofia Miceli, Teresa V. Fiorentino, Elena Succurro, Maria Perticone, Franco Arturi, Marta L. Hribal, Tiziana Montalcini, Francesco Andreozzi, Giorgio Sesti, Arturo Pujia and Angela Sciacqua
    Citation: Cardiovascular Diabetology 2024 23:89
    Content type: Research Published on:

  44. Type-2 diabetes (T2D) worsens stroke recovery, amplifying post-stroke disabilities. Currently, there are no therapies targeting this important clinical problem. Sodium-glucose cotransporter 2 inhibitors (SGLT2...

    Authors: Ellen Vercalsteren, Dimitra Karampatsi, Carolina Buizza, Thomas Nyström, Thomas Klein, Gesine Paul, Cesare Patrone and Vladimer Darsalia
    Citation: Cardiovascular Diabetology 2024 23:88
    Content type: Research Published on:

  45. Insulin resistance (IR) is involved in the pathophysiological processes of arrhythmias. Increasing evidence suggests triglyceride and glucose (TyG) index, metabolic score for insulin resistance (METS-IR), trig...

    Authors: Zhe Wang, Haoming He, Yingying Xie, Jiaju Li, Fangyuan Luo, Zhaowei Sun, Shuwen Zheng, Furong Yang, Xuexi Li, Xiaojie Chen, Yingwei Chen and Yihong Sun
    Citation: Cardiovascular Diabetology 2024 23:87
    Content type: Research Published on:

  46. Studies on the relationship between insulin resistance (IR) surrogates and long-term all-cause mortality in patients with coronary heart disease (CHD) and hypertension are lacking. This study aimed to explore ...

    Authors: Xin-Zheng Hou, Yan-Fei Lv, Yu-Shan Li, Qian Wu, Qian-Yu Lv, Ying-Tian Yang, Lan-Lan Li, Xue-Jiao Ye, Chen-Yan Yang, Man-Shi Wang, Lin-Lin Cao and Shi-Han Wang
    Citation: Cardiovascular Diabetology 2024 23:86
    Content type: Research Published on:

  47. Non-alcoholic fatty liver disease (NAFLD), identified by the Fatty Liver Index (FLI), is associated with increased mortality and cardiovascular (CV) outcomes. Whether this also applies to type 1 diabetes (T1D)...

    Authors: Monia Garofolo, Daniela Lucchesi, Massimo Giambalvo, Michele Aragona, Alessandra Bertolotto, Fabrizio Campi, Cristina Bianchi, Paolo Francesconi, Piero Marchetti, Stefano Del Prato and Giuseppe Penno
    Citation: Cardiovascular Diabetology 2024 23:85
    Content type: Research Published on:

  48. The Stress hyperglycemia ratio (SHR) is a novel marker reflecting the true acute hyperglycemia status and is associated with clinical adverse events. The relationship between SHR and mortality in patients with...

    Authors: Lei Ding, Hongda Zhang, Cong Dai, Aikai Zhang, Fengyuan Yu, Lijie Mi, Yingjie Qi and Min Tang
    Citation: Cardiovascular Diabetology 2024 23:84
    Content type: Research Published on:

  49. Intensive glycemic control reduced coronary artery disease (CAD) events among the Action to Control Cardiovascular Disease Risk in Diabetes (ACCORD) participants with the haptoglobin (Hp) 2-2 phenotype only. I...

    Authors: Rachel A. Warren, Michael P. Bancks, Allie S. Carew, Andrew P. Levy, John Sapp, Judy Bahnson, Cora E. Lewis, Eric B. Rimm, Mark A. Espeland and Leah E. Cahill
    Citation: Cardiovascular Diabetology 2024 23:82
    Content type: Research Published on:

  50. Current literature is deficient in robust evidence delineating the correlation between the triglyceride glucose-body mass index (TyG-BMI) and the incidence of stroke. Consequently, this investigation seeks to ...

    Authors: Yuankai Shao, Haofei Hu, Qiming Li, Changchun Cao, Dehong Liu and Yong Han
    Citation: Cardiovascular Diabetology 2024 23:81
    Content type: Research Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    9.3 - 2-year Impact Factor
    9.6 - 5-year Impact Factor
    2.054 - SNIP (Source Normalized Impact per Paper)
    2.361 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    56 days submission to accept (Median)

    2023 Usage 
    2,523,778 downloads
    3,115 Altmetric mentions 

Cardiovascular Diabetology

ISSN: 1475-2840